NON-SMALL CELL LUNG
Clinical trials for NON-SMALL CELL LUNG explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise in early cancer trial
Disease control Recruiting nowThis early-stage study tests a new medicine, PF-08046033, in adults with advanced lung, esophageal, or skin cancer that has spread or can't be removed. The main goal is to check safety and find the right dose. Participants receive the drug in cycles and are closely watched for si…
Matched conditions: NON-SMALL CELL LUNG
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 03:48 UTC
-
New drug EPI-326 enters first human tests for tough cancers
Disease control Recruiting nowThis early-phase study tests a new drug called EPI-326 in about 110 people with advanced lung cancer (with a specific EGFR gene change) or head/neck cancer. The main goal is to check safety and find the best dose. Participants receive the drug and are monitored for side effects a…
Matched conditions: NON-SMALL CELL LUNG
Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New pill shows promise for tough cancers in early trial
Disease control Recruiting nowThis study tests an experimental pill called veonetinib (AL8326) in people with advanced small cell lung cancer, non-small cell lung cancer, or kidney cancer that has come back or spread. The goal is to find the best dose and see if it shrinks tumors. About 80 adults will take pa…
Matched conditions: NON-SMALL CELL LUNG
Phase: PHASE2 • Sponsor: Advenchen Pharmaceuticals, LLC. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Smart CAR t cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment called A2B395 for adults with advanced solid tumors (like colorectal, lung, breast, and kidney cancers) that have not responded to standard therapy. The treatment uses specially engineered immune cells designed to kill cancer cells while protectin…
Matched conditions: NON-SMALL CELL LUNG
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Massive review of lung cancer care in china launched
Knowledge-focused Recruiting nowThis study looks back at medical records of 3,000 people in China with early-stage non-small cell lung cancer (stages I to III). Researchers want to see what treatments patients received and how they did over time. The goal is to learn about current care patterns to help improve …
Matched conditions: NON-SMALL CELL LUNG
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 26, 2026 03:46 UTC